One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels.

Emily Figueiredo Neves YukiRenata SoaresLéonard de Vinci Kanda KupaCarlos Otto HeiseNadia Emi AikawaMarcelo ArnoneRicardo RomitiTatiana do Nascimento Pedrosa Clovis Artur Almeida da Silva Eloisa S BonfaSandra Gofinet Pasoto

Published in: Lupus (2021)

Our data provides novel evidence of coasting effect in half of asymptomatic patients with TiPN. The irreversible nature of this lesion in 25% of TiPN patients reinforces the relevance of early NCS monitoring, and suggests thalidomide use solely as a bridge for other effective therapy for refractory cutaneous lupus patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
systemic lupus erythematosus
prognostic factors
peritoneal dialysis
risk factors
machine learning
data analysis
deep learning
adverse drug